Dynamic Cost-Offsets of Prescription Drug Expenditures: Panel Data Analysis Using a Copula-Based Hurdle Model
暂无分享,去创建一个
[1] W. Pohlmeier,et al. An inflated multivariate integer count hurdle model : an application to bid and ask quote dynamics , 2011 .
[2] Markku Rahiala,et al. Panel Data , 2011, International Encyclopedia of Statistical Science.
[3] Baoping Shang,et al. Prescription Drug Coverage and Elderly Medicare Spending , 2007 .
[4] Wiji Arulampalam,et al. Simplified Implementation of the Heckman Estimator of the Dynamic Probit Model and a Comparison with Alternative Estimators , 2007, SSRN Electronic Journal.
[5] J. Doshi,et al. Will Part D Produce Savings in Part A and Part B? The Impact of Prescription Drug Coverage on Medicare Program Expenditures , 2007 .
[6] Y. Zhang,et al. Do newer prescription drugs pay for themselves? A reassessment of the evidence. , 2007, Health affairs.
[7] Pravin K. Trivedi,et al. Copula Modeling: An Introduction for Practitioners , 2007 .
[8] Jian Li,et al. Substitution, Spending Offsets, and Prescription Drug Benefit Design , 2007 .
[9] T. Philipson,et al. Integrated Insurance Design in the Presence of Multiple Medical Technologies , 2007, The American economic review.
[10] Andrew J. Patton. Modelling Asymmetric Exchange Rate Dependence , 2006 .
[11] P. Cunningham. Medicaid cost containment and access to prescription drugs. , 2005, Health affairs.
[12] B. Stuart,et al. Assessing the impact of coverage gaps in the Medicare Part D drug benefit. , 2005, Health affairs.
[13] Anirban Basu,et al. Generalized Modeling Approaches to Risk Adjustment of Skewed Outcomes Data , 2003, Journal of health economics.
[14] J. Doshi,et al. Impact of prescription coverage on hospital and physician costs: a case study of medicare beneficiaries with chronic obstructive pulmonary disease. , 2004, Clinical therapeutics.
[15] M. Solomon,et al. Benefits and the Use of Drugs by the Chronically Ill , 2004 .
[16] E. Luciano,et al. Copula methods in finance , 2004 .
[17] Murray D. Smith,et al. On dependency in double-hurdle models , 2003 .
[18] M. Solomon,et al. Employer drug benefit plans and spending on prescription drugs. , 2002, JAMA.
[19] P. Embrechts,et al. Risk Management: Correlation and Dependence in Risk Management: Properties and Pitfalls , 2002 .
[20] F. Lichtenberg,et al. Are the benefits of newer drugs worth their cost? Evidence from the 1996 MEPS. , 2001, Health affairs.
[21] Bill Ravens,et al. An Introduction to Copulas , 2000, Technometrics.
[22] Satishs Iyengar,et al. Multivariate Models and Dependence Concepts , 1998 .
[23] F. Lichtenberg. Do (more and better) drugs keep people out of hospitals? , 1996, The American economic review.
[24] B. Stuart,et al. Are Prescribed and Over‐the-Counter Medicines Economic Substitutes?: A Study of the Effects of Health Insurance on Medicine Choices by the Elderly , 1995, Medical care.
[25] Winfried Pohlmeier,et al. An Econometric Model of the Two-Part Decisionmaking Process in the Demand for Health Care , 1995 .
[26] Jeffrey M. Wooldridge,et al. The Initial Conditions Problem in Dynamic, Nonlinear Panel Data Models with Unobserved Heterogeneity , 2002 .
[27] Willard G. Manning,et al. Choosing Between the Sample-Selection Model and the Multi-Part Model , 1984 .
[28] C. Morris,et al. A Comparison of Alternative Models for the Demand for Medical Care , 1983 .
[29] Lung-fei Lee,et al. Simultaneous Equations Models with Discrete and Censored Variables , 1981 .
[30] D. Clayton. A model for association in bivariate life tables and its application in epidemiological studies of familial tendency in chronic disease incidence , 1978 .
[31] Y. Mundlak. On the Pooling of Time Series and Cross Section Data , 1978 .
[32] Abe Sklar,et al. Random variables, joint distribution functions, and copulas , 1973, Kybernetika.
[33] J. G. Cragg. Some Statistical Models for Limited Dependent Variables with Application to the Demand for Durable Goods , 1971 .